[Funding News] Acculi Labs Raises $1.5 Mn Seed Funding Round From Sabi Holding 

Acculi Labs, a business specializing in health diagnostics, has secured $1.5 million in a seed fundraising round. The funding was primarily provided by Sabi Holding India Ltd.

The company intends to utilize the new funding to enhance the development of its AI insights system, Lyra, advance its micro-entrepreneurial initiative, Lyfas Udyam, and strengthen its joint venture with Sabi Holding.

50% of the proceeds have been designated for the joint venture, while the remaining amount will be distributed to two other ventures.

Acculi Labs also aims to enhance its workforce, operational effectiveness, infrastructure expansion, and manufacturing and production capabilities.

Read also - Clix Capital Raises Rs 220 Cr Funding Round from Existing Investors

Acculi Labs provides services such as point-of-care tests, monitoring, and treatment for chronic diseases.

Acculi Labs offers Lyfas, a mobile application that can capture psychophysiological indicators without invasive methods. It provides a comprehensive health report in just three minutes. In addition, it operates a program known as the Lyfas Udyam initiative, which facilitates the establishment and operation of small firms, so creating an economic opportunity for entrepreneurs.

About Acculi Labs

Founded in 2017 by Rupam Das and Hari Prasath M, The company's flagship product, Lyfas, enables easy and regular early diagnostics and monitoring for early-stage asymptomatic patients and helps them to approach their doctor at an early stage.

Want to go deeper into the world of startups and entrepreneurship? Check out these categories on VIESTORIES:

Startup Success Stories: Discover inspiring tales of startups overcoming challenges and achieving success.

Funding Startup News: Stay updated with the latest news and trends in startup funding and investment.

Startup Insights: Dive into in-depth analyses of various industries and market trends to make informed business decisions.